'Reversible nature of platelet binding causing transfusion-related acute lung injury (TRALI) syndrome may explain dyspnea after ticagrelor and elinogrel' - a hypothesis that remains unproven.
作者： Karsten Schrör , None
DOI: 10.1160/TH12-07-0513
关键词: Surgery 、 Platelet 、 Thrombosis 、 Transfusion-related acute lung injury 、 Lung injury 、 Elinogrel 、 Cardiology 、 Ticagrelor 、 Internal medicine 、 Vascular biology 、 Medicine
摘要: 'Reversible nature of platelet binding causing transfusion-related acute lung injury (TRALI) syndrome may explain dyspnea after ticagrelor and elinogrel' – a hypothesis that remains unproven - Editorial on Serebruany: ‘Viewpoint: Reversible elinogrel’ (Thromb Haemost 2012; 108.6)
sci-hub.se 参考文章(21)
Richard Becker, Stefan James, Robert Harrington, Lars Wallentin, The PLATO trial reveals further opportunities to improve outcomes in patients with acute coronary syndrome Thrombosis and Haemostasis. ,vol. 105, pp. 760- 762 ,(2011) , 10.1160/TH11-03-0162
Li-ming Gan, Ann Wittfeldt, Hakan Emanuelsson, Sven Nylander, Jenny Jonasson, ADENOSINE MAY MEDIATE TICAGRELOR-INDUCED DYSPNEA Journal of the American College of Cardiology. ,vol. 59, ,(2012) , 10.1016/S0735-1097(12)60345-3
Pearl Toy, Ognjen Gajic, Peter Bacchetti, Mark R Looney, Michael A Gropper, Rolf Hubmayr, Clifford A Lowell, Philip J Norris, Edward L Murphy, Richard B Weiskopf, Gregory Wilson, Monique Koenigsberg, Deanna Lee, Randy Schuller, Ping Wu, Barbara Grimes, Manish J Gandhi, Jeffrey L Winters, David Mair, Nora Hirschler, Rosa Sanchez Rosen, Michael A Matthay, TRALI Study Group, None, Transfusion-related acute lung injury: Incidence and risk factors Blood. ,vol. 119, pp. 1757- 1767 ,(2012) , 10.1182/BLOOD-2011-08-370932
J. J. J. van Giezen, James Sidaway, Philip Glaves, Ian Kirk, Jan-Arne Björkman, Ticagrelor Inhibits Adenosine Uptake In Vitro and Enhances Adenosine-Mediated Hyperemia Responses in a Canine Model: Journal of Cardiovascular Pharmacology and Therapeutics. ,vol. 17, pp. 164- 172 ,(2012) , 10.1177/1074248411410883
Victor L. Serebruany, Adenosine release: A potential explanation for the benefits of ticagrelor in the PLATelet Inhibition and Clinical Outcomes trial? American Heart Journal. ,vol. 161, pp. 1- 4 ,(2011) , 10.1016/J.AHJ.2010.09.017
Pearl Toy, Clifford Lowell, TRALI--definition, mechanisms, incidence and clinical relevance. Best Practice & Research Clinical Anaesthesiology. ,vol. 21, pp. 183- 193 ,(2007) , 10.1016/J.BPA.2007.01.003
Victor Serebruany, Viewpoint: Reversible nature of platelet binding causing transfusion-related acute lung injury (TRALI) syndrome may explain dyspnea after ticagrelor and elinogrel Thrombosis and Haemostasis. ,vol. 108, pp. 1024- 1027 ,(2012) , 10.1160/TH12-03-0180
Kylie D Mason, Marina R Carpinelli, Jamie I Fletcher, Janelle E Collinge, Adrienne A Hilton, Sarah Ellis, Priscilla N Kelly, Paul G Ekert, Donald Metcalf, Andrew W Roberts, David CS Huang, Benjamin T Kile, None, Programmed Anuclear Cell Death Delimits Platelet Life Span Cell. ,vol. 128, pp. 1173- 1186 ,(2007) , 10.1016/J.CELL.2007.01.037
Payal Kohli, Jacob Udell, Sabina Murphy, Elliott Antman, Eugene Braunwald, Stephen Wiviott, DISCHARGE ASPIRIN DOSE AND CLINICAL OUTCOMES IN PATIENTS WITH ACS: AN ANALYSIS FROM THE TRITON-TIMI 38 STUDY Journal of the American College of Cardiology. ,vol. 59, ,(2012) , 10.1016/S0735-1097(12)60343-X
Robert Storey, Pharmacology and clinical trials of reversibly-binding P2Y12 inhibitors Thrombosis and Haemostasis. ,vol. 105, ,(2011) , 10.1160/THS10-12-0769